Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 20 04:00PM ET
1.70
Dollar change
+0.17
Percentage change
11.11
%
Index- P/E- EPS (ttm)-4.14 Insider Own69.30% Shs Outstand37.16M Perf Week1.19%
Market Cap66.50M Forward P/E- EPS next Y-0.87 Insider Trans0.00% Shs Float12.01M Perf Month-63.52%
Income-141.82M PEG- EPS next Q-0.19 Inst Own15.24% Short Float1.60% Perf Quarter-83.96%
Sales0.00M P/S- EPS this Y-1909.52% Inst Trans4.33% Short Ratio1.94 Perf Half Y-63.91%
Book/sh-5.20 P/B- EPS next Y77.11% ROA-1150.77% Short Interest0.19M Perf Year-83.62%
Cash/sh0.04 P/C42.63 EPS next 5Y- ROE-27.38% 52W Range1.38 - 17.17 Perf YTD-76.39%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-90.10% Beta0.45
Dividend TTM- Quick Ratio0.16 Sales past 5Y0.00% Gross Margin- 52W Low23.19% ATR (14)0.56
Dividend Ex-Date- Current Ratio0.16 EPS Y/Y TTM-4975.41% Oper. Margin0.00% RSI (14)27.18 Volatility10.18% 15.58%
Employees10 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price6.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-16223.20% Payout- Rel Volume1.41 Prev Close1.53
Sales Surprise- EPS Surprise-922.58% Sales Q/Q- EarningsMay 14 AMC Avg Volume99.03K Price1.70
SMA20-38.32% SMA50-76.34% SMA200-75.03% Trades Volume137,427 Change11.11%
Date Action Analyst Rating Change Price Target Change
Aug-18-23Initiated H.C. Wainwright Buy $18
May-14-24 04:05PM
May-09-24 09:35AM
08:00AM
May-03-24 04:08PM
03:55PM
02:37PM Loading…
02:37PM
09:05AM
08:31AM
07:00AM
Mar-30-24 10:53PM
Mar-29-24 04:15PM
03:45PM
Mar-19-24 04:30PM
04:29PM
Jan-18-24 04:05PM
08:00AM Loading…
Dec-12-23 08:00AM
Nov-15-23 04:49AM
Nov-13-23 08:15AM
Oct-19-23 04:05PM
Aug-29-23 08:00AM
Aug-24-23 08:00AM
Aug-16-23 07:00AM
Jul-24-23 07:00AM
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strathspey Crown Holdings Grou10% OwnerAug 11 '23Sale10.007,380,39473,803,9402,031,773Aug 14 04:10 PM